Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
Clinical trial NCT05651672 · RECRUITING
Trial details
- NCT number
- NCT05651672
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2024-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.